139 related articles for article (PubMed ID: 2878745)
41. A review and meta-analysis of hormonal treatment of cryptorchidism.
Pyörälä S; Huttunen NP; Uhari M
J Clin Endocrinol Metab; 1995 Sep; 80(9):2795-9. PubMed ID: 7673426
[TBL] [Abstract][Full Text] [Related]
42. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
[TBL] [Abstract][Full Text] [Related]
43. Effect of LH-RH treatment on hypothalamo-pituitary-gonadal axis and Leydig cell ultrastructure in cryptorchid boys.
Hadziselimovic F; Girard J; Höcht B; von der Ohe M; Stalder G
Horm Res; 1980; 13(6):358-66. PubMed ID: 6115808
[TBL] [Abstract][Full Text] [Related]
44. Hormonal treatment of cryptorchidism.
de Muinck Keizer-Schrama SM
Horm Res; 1988; 30(4-5):178-86. PubMed ID: 2907895
[TBL] [Abstract][Full Text] [Related]
45. Sexual impotence: a double-blind study of LHRH nasal spray versus placebo.
Benkert O; Jordan R; Dahlen HG; Schneider HP; Gammel G
Neuropsychobiology; 1975; 1(4):203-10. PubMed ID: 775358
[TBL] [Abstract][Full Text] [Related]
46. Comparison of five different hormonal treatment protocols for children with cryptorchidism.
Esposito C; De Lucia A; Palmieri A; Centonze A; Damiano R; Savanelli A; Valerio G; Settimi A
Scand J Urol Nephrol; 2003; 37(3):246-9. PubMed ID: 12775284
[TBL] [Abstract][Full Text] [Related]
47. [Endocrine data in cryptorchism].
Gendrel D; Job JC; Canlorbe P; Roger M; Laclyde JP
Arch Fr Pediatr; 1978 May; 35(5):535-45. PubMed ID: 28100
[TBL] [Abstract][Full Text] [Related]
48. Prospective study of histological and endocrine parameters of gonadal function in boys with cryptorchidism.
Verkauskas G; Malcius D; Eidukaite A; Vilimas J; Dasevicius D; Bilius V; Hadziselimovic F
J Pediatr Urol; 2016 Aug; 12(4):238.e1-6. PubMed ID: 27321556
[TBL] [Abstract][Full Text] [Related]
49. [Therapy of prepubertal cryptorchism. Clinical experiences with LH-RH treatment].
Höcht B
Fortschr Med; 1983 Sep; 101(34):1531-5. PubMed ID: 6138302
[TBL] [Abstract][Full Text] [Related]
50. [LHRH and cryptorchism. The results in a selected group of patients].
Agliardi AC; Borzani M; Olivani P
Pediatr Med Chir; 1990; 12(4):371-3. PubMed ID: 1981611
[TBL] [Abstract][Full Text] [Related]
51. Long-term effect of luteinizing hormone-releasing hormone analogue (buserelin) on cryptorchid testes.
Hadziselimović F; Huff D; Duckett J; Herzog B; Elder J; Snyder H; Buser M
J Urol; 1987 Oct; 138(4 Pt 2):1043-5. PubMed ID: 2888905
[TBL] [Abstract][Full Text] [Related]
52. Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: a clinical trial.
Nane I; Ziylan O; Esen T; Kocak T; Ander H; Tellaloglu S
Urology; 1997 Jan; 49(1):108-11. PubMed ID: 9000196
[TBL] [Abstract][Full Text] [Related]
53. Predictive value of luteinizing hormone releasing hormone (LHRH) bolus testing before and after 36-hour pulsatile LHRH administration in the differential diagnosis of constitutional delay of puberty and male hypogonadotropic hypogonadism.
Smals AG; Hermus AR; Boers GH; Pieters GF; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1994 Mar; 78(3):602-8. PubMed ID: 8126131
[TBL] [Abstract][Full Text] [Related]
54. Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
Hall MC; Fritzsch RJ; Sagalowsky AI; Ahrens A; Petty B; Roehrborn CG
Urology; 1999 May; 53(5):898-902; discussion 902-3. PubMed ID: 10223480
[TBL] [Abstract][Full Text] [Related]
55. Plasma gonadotropin and testosterone values in infants with cryptorchidism.
Gendrel D; Roger M; Job JC
J Pediatr; 1980 Aug; 97(2):217-20. PubMed ID: 6105174
[TBL] [Abstract][Full Text] [Related]
56. Intra- and inter-observer variability in the assessment of testicular descent.
Wit JM; Delemarre-van der Waal HA; Faber JA; Van den Brande JL
Andrologia; 1987; 19(5):585-90. PubMed ID: 2892435
[TBL] [Abstract][Full Text] [Related]
57. Correlation of pituitary and testicular responses to stimulation tests in cryptorchid children.
Gendrel D; Roger M; Chaussain JL; Canlorbe P; Job JC
Acta Endocrinol (Copenh); 1977 Nov; 86(3):641-50. PubMed ID: 21503
[TBL] [Abstract][Full Text] [Related]
58. Use of luteinizing-hormone-releasing hormone nasal spray in the treatment of cryptorchidism: is there still an indication? A clinical study in 78 boys with 103 undescended testicles.
Witjes JA; de Vries JD; Lock MT; Debruyne FM
Eur Urol; 1990; 17(3):226-8. PubMed ID: 1972065
[TBL] [Abstract][Full Text] [Related]
59. Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy.
Happ J; Kollmann F; Krawehl C; Neubauer M; Krause U; Demisch K; Sandow J; Von Rechenberg W; Beyer J
Fertil Steril; 1978 May; 29(5):546-51. PubMed ID: 27391
[TBL] [Abstract][Full Text] [Related]
60. Recovery of Serum Testosterone Levels and Sexual Function in Patients Treated With Short-term Luteinizing Hormone-releasing Hormone Antagonist as a Neoadjuvant Therapy Before External Radiotherapy for Intermediate-risk Prostate Cancer: Preliminary Prospective Study.
Inoue T; Mizowaki T; Kabata D; Shintani A; Terada N; Yamasaki T; Negoro H; Kobayashi T; Nakamura K; Inokuchi H; Ogawa O
Clin Genitourin Cancer; 2018 Apr; 16(2):135-141.e1. PubMed ID: 29051056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
